Simdax

DRUG2 trials

Sponsors

Medical University Of Gdansk, Yooyoung Pharmaceutical Co., Ltd.

Conditions

Acute Decompensated Heart FailureTakotsubo syndrome

Phase 3

Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX

Yooyoung Pharmaceutical Co., Ltd.Acute Decompensated Heart Failure

Start: 2019-01-11End: 2022-07-30Target: 112Updated: 2021-05-11

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Levosimendan Therapy in low ejection fraction Takotsubo Syndrome (LevoTako Trial)

CompletedCTIS2024-515060-32-00

Medical University Of GdanskTakotsubo syndrome

Start: 2024-11-22End: 2025-12-22Target: 190Updated: 2025-12-14